Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
1998 1
1999 1
2000 3
2001 5
2002 9
2003 8
2004 7
2005 15
2006 20
2007 17
2008 22
2009 21
2010 14
2011 15
2012 19
2013 16
2014 23
2015 21
2016 31
2017 26
2018 27
2019 39
2020 45
2021 57
2022 54
2023 36
2024 30
2025 57
2026 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

598 results

Results by year

Filters applied: . Clear all
Page 1
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role.
Raal FJ, Giugliano RP, Sabatine MS, Koren MJ, Blom D, Seidah NG, Honarpour N, Lira A, Xue A, Chiruvolu P, Jackson S, Di M, Peach M, Somaratne R, Wasserman SM, Scott R, Stein EA. Raal FJ, et al. Among authors: sabatine ms. J Lipid Res. 2026 Jun 13;67(6):101063. doi: 10.1016/j.jlr.2026.101063. Online ahead of print. J Lipid Res. 2026. PMID: 42288054 Free article. No abstract available.
Evolocumab in Patients With High-Risk Diabetes: Results From the VESALIUS-CV Trial.
Leiter LA, Giugliano RP, Marston NA, De Ferrari G, Nicolau JC, Bhatia AK, Cyrille M, Park JG, Kuder JF, Murphy SA, Liu L, Walsh E, Wang H, Džupina A, Ferreira J, Gouni-Berthold I, Jensen HK, Kuusisto J, Pella D, Sattar N, Tsioufis KP, Vinereanu D, Paiva da Silva Lima G, Sabatine MS, Bohula EA. Leiter LA, et al. Among authors: sabatine ms. Diabetes Care. 2026 Jun 7:dc260847. doi: 10.2337/dc26-0847. Online ahead of print. Diabetes Care. 2026. PMID: 42251764
Safety of low lipoprotein(a) levels: the FOURIER trial.
Gencer B, Giugliano RP, Ran X, Mach F, Stroes ESG, Gouni-Berthold I, Češka R, Ezhov MV, Jukema JW, Jensen HK, Tokgözoğlu SL, Huber K, Im K, Sabatine MS, O'Donoghue ML. Gencer B, et al. Among authors: sabatine ms. Eur Heart J. 2026 Jun 3:ehag398. doi: 10.1093/eurheartj/ehag398. Online ahead of print. Eur Heart J. 2026. PMID: 42234492
Lipoprotein(a) Levels, Risk of Cardiovascular Events and Benefit of Evolocumab: Findings From the VESALIUS-CV Trial.
Monguillon V, Marston NA, Bohula EA, Park JG, Kuder JF, Murphy SA, De Ferrari GM, Leiter LA, Nicolau JC, Ebenbichler C, Sinnaeve P, Goudev A, Budaj A, Averkov O, Tokgozoglu L, Blankstein R, Vinereanu D, Giugliano RP, Sabatine MS, O'Donoghue ML. Monguillon V, et al. Among authors: sabatine ms. Circulation. 2026 May 25. doi: 10.1161/CIRCULATIONAHA.126.080999. Online ahead of print. Circulation. 2026. PMID: 42183757 Free article.
Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior MI: Results From the VESALIUS-CV Trial.
Bergmark BA, Bohula EA, Marston NA, Park JG, Kuder JF, Murphy SA, De Ferrari GMM, Leiter LA, Nicolau JC, Averkov O, Charng MJ, Ebenbichler C, Erglis A, Gouni-Berthold I, Montalescot G, Nicholls SJ, Sigurdsson A, Sinnaeve P, Slapikas R, Tsioufis K, Verma S, Viigimaa M, Bhatia AK, Xin L, Walsh E, Ohman EM, Giugliano RP, Sabatine MS. Bergmark BA, et al. Among authors: sabatine ms. Circulation. 2026 May 19. doi: 10.1161/CIRCULATIONAHA.126.080616. Online ahead of print. Circulation. 2026. PMID: 42153665
Rare coding variant architecture and gene discovery from 130,000 sequenced cases of atrial fibrillation.
Jurgens SJ, Enzan N, Dinsmore IR, Choi SH, Luo J, Lipov A, Hartle C, Wang X, Marston NA, Weng LC, Melloni GE, Chalazan B, Gray MP, Pirruccello JP, Diaz A, Chaffin MD, Ornelas-Loredo A, Tang O, Darbar FA, Kany S, Chen Y, von Falkenhausen AS, Morrison AC, Natale A, Tveit A, Geelhoed B, Cade B, Van Wagoner DR, Haase D, Soliman EZ, Davogustto GE, Calkins H, Anderson JL, Brody JA, Barnard J, Hokanson JE, Smith JD, Bis JC, Young K, Johnson LS, Long L, Risch L, Gula LJ, Kwee LC, Kühne M, Preuss M, Gupta N, Nafissi NA, Smith NL, Nilsson PM, van der Harst P, Wells QS, Judy RL, Schnabel RB, Johnson R, Smit RA, Gabriel S, Knight S, Furukawa T, Min YI, Yoneda ZT, Laksman ZW, Alonso A, Psaty BM, Albert CM, Arking DE, Roden DM, Chasman DI, Rader DJ, Conen D, McManus DD, Fatkin D, Boerwinkle E, Marcus GM, Christophersen IE, Smith JG, Roberts JD, Raffield LM, Shoemaker MB, Cho MH, Cutler MJ, Chung MK, Olesen MS, Sinner MF, Sotoodehnia N, Kirchhof P, Loos RJ, Nazarian S, Mohanty S, Damrauer SM, Kaab S, Heckbert SR, Redline S, Shah SH, Tanaka T, Ebana Y; Regeneron Genetics Center; NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium; Lubitz SA, Lunetta KL, Benjamin EJ, Rienstra M, Figtree G… See abstract for full author list ➔ Jurgens SJ, et al. Among authors: sabatine ms. Res Sq [Preprint]. 2026 May 4:rs.3.rs-9191644. doi: 10.21203/rs.3.rs-9191644/v1. Res Sq. 2026. PMID: 42147184 Free PMC article. Preprint.
Early Versus Late Initiation of Evolocumab and Arterial Aneurysm Events: An Analysis of FOURIER and FOURIER-OLE.
Zimerman A, Gaba P, O'Donoghue ML, Giugliano RP, Murphy SA, Ran X, Kuder JF, Ceska R, De Ferrari GM, Ferreira J, Gaciong ZA, Lopez-Sendon J, Lorenzatti A, Saraiva JFK, Jukema JW, Monsalvo ML, Flores-Arredondo JH, Atar D, Keech AC, Sabatine MS, Marston NA, Bergmark BA. Zimerman A, et al. Among authors: sabatine ms. Circulation. 2026 May 12;153(19):1516-1519. doi: 10.1161/CIRCULATIONAHA.125.077140. Epub 2026 May 11. Circulation. 2026. PMID: 42113916 No abstract available.
598 results